06/08/2018 | 3009571102 | La Vita Compounding Pharmacy, LLC | 483 | CA | Producer of Sterile Drug Products | 07/02/2018 |
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, July 3, 2018
Monday, July 2, 2018
DEA News
Ljudmil Kljusev, M.D.; Decision and Order (July 2, 2018)
Mohammed Asgar, M.D.; Decision and Order (June 25, 2018)
Kevin G. Morgan, RN/APN; Decision and Order (June 25, 2018)
Unither Manufacturing LLC (June 22, 2018)
Bulk Manufacturer of Controlled Substances Registration (June 20, 2018)
Fisher Clinical Services, Inc. (June 20, 2018)
American Radiolabeled Chem (June 20, 2018)
Cerilliant Corporation (June 20, 2018)
Importer of Controlled Substances Registration (June 15, 2018)
Minnesota sues OxyContin maker
Winona Daily News-7 hours ago
The lawsuit, filed Monday by state Attorney General Lori Swanson in ... through a variety of efforts, including the state Board of Pharmacy's monitoring activities to ...
MN Attorney General sues opioid maker Purdue Pharma, says it ...
TwinCities.com-Pioneer Press-6 hours ago
TwinCities.com-Pioneer Press-6 hours ago
Congress, Feds, FDA Take Action to Combat Opioid Crisis
Pharmaceutical Executive (press release) (blog)-19 hours ago
As part of ongoing FDA efforts to reduce illegal opioid prescribing and distribution, the agency seeks to curb the rise in opoid sales through online pharmacies.
FDA Withdraws Draft Guidance on Biosimilar Development
BioSpace (press release) (blog)-44 minutes ago
The U.S. Food and Drug Administration (FDA) withdrew its draft guidance on statistical methods to evaluate the analytical similarity between branded drugs and
Mylan plant slapped with 32-page FDA Form 483
FiercePharma-10 hours ago
When Mylan recently announced 500 layoffs at its plant in West Virginia, it said the cuts were “consistent to discussions it was having with the FDA.” What it didn't ...
Mylan site receives US FDA 483, commits to 'robust improvement plan'
In-PharmaTechnologist.com-13 hours ago
In-PharmaTechnologist.com-13 hours ago
Subscribe to:
Posts (Atom)